Bioventus Inc (BVS) — Cash Flow-to-Debt Ratio
Bioventus Inc (BVS) has a Cash Flow-to-Debt Ratio of 0.05x as of June 2026, meaning its operating cash flow of $19.87 Million could theoretically repay 0% of its total liabilities ($395.93 Million) in one year. See BVS financial flexibility score to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Bioventus Inc Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Bioventus Inc across 10 annual periods. For the full cash flow conversion analysis, see Bioventus Inc (BVS) cash conversion ratio.
Annual Cash Flow-to-Debt Ratio for Bioventus Inc (2014–2025)
Year-by-year debt coverage analysis for Bioventus Inc. Check how high is Bioventus Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | $73.98 Million | $455.11 Million | ▲ +127.2% |
| 2024 | 0.07x | $38.80 Million | $542.35 Million | ▲ +175.0% |
| 2023 | 0.03x | $15.34 Million | $589.79 Million | ▲ +284.6% |
| 2022 | -0.01x | $-13.54 Million | $960.43 Million | ▼ -142.4% |
| 2021 | 0.03x | $22.99 Million | $692.07 Million | ▼ -83.8% |
| 2020 | 0.20x | $71.80 Million | $350.31 Million | ▲ +64.5% |
| 2019 | 0.12x | $40.71 Million | $326.79 Million | ▼ -18.0% |
| 2018 | 0.15x | $45.19 Million | $297.46 Million | ▲ +136.9% |
| 2015 | 0.06x | $18.92 Million | $295.01 Million | ▲ +7.4% |
| 2014 | 0.06x | $15.11 Million | $252.93 Million | — |